|Bid||1.83 x 2000|
|Ask||1.90 x 100|
|Day's Range||1.82 - 1.89|
|52 Week Range||0.19 - 4.96|
|PE Ratio (TTM)||-0.19|
|Earnings Date||May 18, 2017 - May 19, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||9.00|
NEW YORK, NY / ACCESSWIRE / July 7, 2017 / Valeant may be selling off more units soon to pay off its nearly $29 billion debt. The company just recently closed on its sale of its Dendreon subsidiary to ...
Celsion Corp. (CLSN) shares rose after the company has announced completion of enrolment in a phase Ib study, evaluating its immunotherapy, GEN-1 in combination with neoadjuvant chemotherapy for treatment of advanced ovarian cancer.
LAWRENCEVILLE, N.J., July 06, 2017-- Celsion Corporation today announced that it has entered into definitive agreements with several institutional investors to purchase an aggregate of approximately $5 ...